Skip to main content
LUCD
NASDAQ Industrial Applications And Services

Lucid Diagnostics Q2 Loss Widens; Going Concern Doubt Persists

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.988
Mkt Cap
$199.899M
52W Low
$0.861
52W High
$1.629
52W Position info
15% above low
Off High info
39% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

LUCD is trading near its 52-week low of $0.861 (15% above the low).

Summary

Lucid Diagnostics posted a wider Q2 loss and reiterated going concern doubt, with a key debt waiver expiring August 22. Heavy dilution from offerings and preferred conversions added over 59 million shares in six months.


Key Events · Earnings and Guidance · LUCD

  • Q2 Loss Widens to $14.7M

    Net loss attributable to common stockholders was $14.7 million for Q2 2026, up from $7.9 million in Q2 2025, driven by higher sales and marketing spend.

  • Going Concern Doubt Reiterated

    Management again stated substantial doubt about the company's ability to continue as a going concern within one year, citing recurring losses and negative operating cash flow.

  • Debt Waiver Expires August 22

    A waiver from 2024 Convertible Note holders covering the missed Medicare coverage milestone expires August 22, 2026; failure to extend could trigger default.

  • Heavy Dilution in H1 2026

    Shares outstanding rose to 190.8 million from 131.1 million at year-end, driven by an 18-million-share registered direct offering at $1.00, ATM sales, and preferred stock conversions.


Analysis · LUCD · Industrial Applications And Services

Lucid Diagnostics reported a Q2 net loss of $14.7 million attributable to common stockholders, up from $7.9 million a year ago, while revenue grew 27% to $1.5 million. The company reiterated substantial doubt about its ability to continue as a going concern, with only $33.4 million in cash and a $23.5 million convertible note liability classified as current. A waiver from noteholders covering a missed Medicare coverage milestone expires August 22, 2026, leaving near-term default risk. The quarter also saw heavy dilution: an 18-million-share registered direct offering at $1.00 and ATM sales added over 22 million shares, while preferred stock conversions and dividends pushed total shares outstanding to 190.8 million from 131.1 million at year-end.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LUCD was trading at $0.99 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $199.9M. The 52-week trading range was $0.86 to $1.63. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LUCD - Latest Insights

LUCD
Nov 12, 2026, 8:11 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.4212
Real-time Price: $0.4022 info
Change: -$0.019 (-5%) info
Market Cap: $82.336M info
LUCD
Nov 12, 2026, 8:05 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4212
Real-time Price: $0.4022 info
Change: -$0.019 (-5%) info
Market Cap: $82.336M info
LUCD
Nov 12, 2026, 8:00 AM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.4212
Real-time Price: $0.4022 info
Change: -$0.019 (-5%) info
Market Cap: $82.336M info
LUCD
Oct 22, 2026, 6:18 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.5152
Real-time Price: $0.4022 info
Change: -$0.113 (-22%) info
Market Cap: $82.336M info
LUCD
Oct 22, 2026, 4:34 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3584
Real-time Price: $0.4022 info
Change: +$0.0438 (+12%) info
Market Cap: $82.336M info